Advisor Group Holdings, Inc. Mesoblast LTD Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.0 - $1.39 $34 - $47	34 Added 41.46%	116 $0
Q3 2023 Nov 13, 2023	SELL	$1.22 - $4.83 $9 - $38	-8 Reduced 8.89%	82 $0
Q2 2023 Aug 10, 2023	BUY	$2.95 - $4.44 $76 - $115	26 Added 40.63%	90 $0
Q3 2022 Nov 14, 2022	SELL	$0.48 - $3.48 $1,003 - $7,273	-2,090 Reduced 97.03%	64 $0
Q2 2022 Aug 10, 2022	SELL	$2.22 - $4.54 $2,220 - $4,540	-1,000 Reduced 31.71%	2,154 $4,000
Q1 2022 May 04, 2022	BUY	$3.58 - $4.98 $229 - $318	64 Added 2.07%	3,154 $13,000
Q1 2021 May 13, 2021	SELL	$8.26 - $11.4 $20,030 - $27,645	-2,425 Reduced 43.97%	3,090 $26,000
Q4 2020 Feb 10, 2021	SELL	$8.21 - $18.59 $3,530 - $7,993	-430 Reduced 7.23%	5,515 $46,000
Q3 2020 Nov 12, 2020	BUY	$11.33 - $19.81 $36,256 - $63,391	3,200 Added 116.58%	5,945 $110,000
Q2 2020 Aug 14, 2020	BUY	$4.2 - $15.45 $999 - $3,677	238 Added 9.49%	2,745 $31,000
Q1 2020 May 18, 2020	BUY	$3.38 - $10.63 $8,473 - $26,649	2,507 New	2,507 $6,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.